Cancer Diagnostics Market Share

Statistics for the 2023 & 2024 Cancer Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Cancer Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Cancer Diagnostics Industry

The cancer diagnostics market is highly fragmented with the presence of a large number of local and international players. Key players are adopting different growth strategies to enhance their market presence such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientifica Inc., and Qiagen.

Cancer Diagnostics Market Leaders

  1. F. Hoffmann-La Roche Ltd

  2. Thermo Fisher Scientific Inc.

  3. Abbott Laboratories Inc.

  4. Illumina Inc

  5. bioMérieux SA

*Disclaimer: Major Players sorted in no particular order

Cancer Diagnostics Market Concentration

Cancer Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)